The IPO isn’t coming this year. That’s the signal from reporting by the New York Times, which cited three people involved in OpenAI’s deliberations in describing a choice the company’s advisers have laid out: wait until 2027, target a $1 trillion valuation, or go public sooner at a lower number. OpenAI has not issued a public statement confirming either path.
The $1 trillion figure matters because of what it represents, not just its size. According to the Times, advisers framed $1 trillion as a threshold worth waiting for, which means the current market isn’t being read as supportive of that number today. The alternative, a quicker public debut at a lower valuation, was presented as the other option. OpenAI’s reported lean toward patience tells you which way the internal conversation is moving, even if nothing is final.
Markets noticed. SoftBank Group’s stock fell sharply on the news, shedding roughly $38 billion in market value. That reaction isn’t incidental. SoftBank has significant exposure to OpenAI, and a delay to 2027 pushes the timeline for any liquidity event tied to that position. When a publicly traded holding company drops on a portfolio company’s IPO delay, investors are saying something specific: the IPO timeline was already priced in.
This story doesn’t exist in isolation. OpenAI’s S-1 was reported filed confidentially in early June. The progression from “S-1 filed” to “leaning toward 2027” in under a month isn’t a reversal, it’s a negotiation playing out in public, with advisers, executives, and potential investors each sending signals through the press. xAI, Anthropic, and OpenAI have all been described as heading toward public markets. OpenAI pushing to 2027 changes the sequencing question for the whole cohort.
The SoftBank data point is worth holding onto. It’s the third major AI IPO-adjacent market signal, following Anthropic’s reported confidential filing and xAI’s investor roadshow activity. Each development is being priced in real time by investors who’ve built positions in the AI IPO pipeline. A delay at OpenAI doesn’t just affect OpenAI shareholders, it resets expectations for how long the private-to-public transition takes for frontier AI companies generally.
What to watch
OpenAI’s next formal communication to investors or employees on IPO timeline. Any change in SoftBank’s stated OpenAI position. Whether Anthropic’s filing accelerates in response to OpenAI’s reported delay, the sequencing race is real, and second-mover disadvantage in a hot IPO window is a genuine consideration for every lab watching this play out.
What to Watch
The real story here isn’t the delay. It’s the valuation math. Advisers aren’t telling OpenAI to wait because the company isn’t ready, they’re telling it to wait because the market isn’t yet pricing the company at the number that makes going public worth it. That’s a meaningful signal about where institutional appetite for frontier AI equity actually sits right now, regardless of the headline valuations attached to private rounds. Watch Anthropic’s next move. That’s where the sequencing decision gets made.
Sources: Reuters, Qz, The New York Times.